Scopolamine Market Players:
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Baxter International Inc.
- Myungmoon Pharm Co. Ltd
- Alchem International Pvt. Ltd.
- Caleb Pharmaceuticals, Inc.
- GlaxoSmithKline plc
- Aktivax, Inc.
- Southwest Research Institute
- Perrigo Company plc
- Novartis International AG
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of scopolamine is evaluated at USD 472.41 million.
The global scopolamine market size was worth around USD 449.74 million in 2025 and is set to register a CAGR of more than 5.6%, exceeding USD 775.53 million revenue by 2035.
Asia Pacific is projected to command a leading revenue share of 32% by 2035, owing to the rising prevalence of ophthalmic disorders, increasing surgical procedures among the elderly, and expanding clinical applications across therapeutic areas.
Key players in the market include Voith GmbH & Co. KGaA, LITOSTROJ POWER d.o.o., Toshiba Energy Systems & Solutions Corporation, GE Group, Siemens AG, ANDRITZ Hydro, Kirloskar Brothers Limited, Harbin Electric Machinery Company Limited, Canyon Hydro, Cornell Pump Company.
